摘要
目的 探讨恶性卵巢甲状腺肿的临床诊断、治疗及分子遗传学特征,以提高临床诊治水平。方法 结合1例诊断为恶性卵巢甲状腺肿13年后来本院接受手术治疗的病例,复习文献,总结经验。结果 患者无生育要求,经与患者及家属充分沟通后,联合多学科讨论制定手术方案及术后支持治疗计划,顺利实施肿瘤细胞减灭术。术中见盆腹腔病灶广泛,仔细探查并完整切除,手术达到R0切除。术后恢复良好,未行补充治疗,持续严密随访。结论 恶性卵巢甲状腺肿(MSO)是一种罕见但具有潜在威胁的卵巢肿瘤,术后需长期随访,多学科综合诊疗是改善患者预后的关键。
Objective To explore the clinical diagnosis,treatment,and molecular genetic characteristics of malignant struma ovarii(MSO),and to improve the level of clinical diagnosis and treatment.Methods Com-bined with a case who was diagnosed with MSO and came to the hospital for surgical treatment 13 years later,the literature was reviewed and the experience was summarized.Results The patient had no child-bearing desire.After full communication with the patient and her family,a surgical plan and postoperative supportive treatment plan were formulated through multidisciplinary discussion,and cytoreductive surgery was successfully performed.Intraoperatively,extensive pelvic and abdominal lesions were revealed;thus,patient exploration and complete resection were performed,and R0 resection was achieved.Postoperative-ly,the patient recovered well,no adjuvant treatment was administered,and continues to undergo continu-ous close follow-up.Conclusion MSO is a rare but potentially threatening ovarian tumor.The multidisci-plinary diagnosis and treatment model is the first choice.With the development of molecular genetics,more benefits will be brought to the patients.
作者
袁敏
王维娜
刘小山
熊廷川
袁建林
YUAN Min;WANG Weina;LIU Xiaoshan;XIONG Tingchuan;YUAN Jianlin(Department of Gynecology,Affiliated Cancer Hospital of Xinjiang Medical University,Urumqi 830011,China;Department of Pathology,Affiliated Cancer Hospital of Xinjiang Medical University,Urumqi 830011,China)
出处
《新疆医科大学学报》
2025年第12期1654-1658,共5页
Journal of Xinjiang Medical University
基金
新疆维吾尔自治区天山英才医药卫生高层次中青年骨干人才培养项目(TSYC202401B038)。
关键词
恶性卵巢甲状腺肿
多学科诊疗
治疗
分子遗传学
malignant struma ovarii
multidisciplinary diagnosis and treatment model
treatment
follow-up
prognosis
